CONTEXT: Although epidemiological studies have reported protective effects of religion and spirituality on mental health, it is unknown whether spirituality can be used as an intervention to improve psychological well-being. OBJECTIVE: To evaluate the efficacy of a home study-based spirituality program on mood disturbance in emotionally distressed patients. DESIGN, SETTING, AND PARTICIPANTS: A non-blinded, randomized, wait list-controlled trial of 165 individuals with mood disturbance [score of >40 on the Profile of Mood States (POMS)] were recruited from primary care clinics in a Canadian city between August 2000 and March 2001. INTERVENTIONS: Participants were randomized to a spirituality group (an 8-week audiotaped spirituality home-study program), a mindfulness meditation-based stress reduction group (attendance at facilitated classes for 8 weeks), or a wait-list control group (no intervention for 12 weeks). MAIN OUTCOME MEASURES: Primary outcomes were mood disturbance, measured using POMS, and quality of life, measured using the SF-36, a short-form health survey with 36 questions. The POMS and the SF-36 were completed at baseline, at 8 weeks, and at 12 weeks. RESULTS: At the end of the 8-week intervention period, the mean POMS score improvement was -43.1 (-45.7%) for the spirituality group, -22.6 (-26.3%) for the meditation group, and -10.3 (11.3%) for the control group (P<.001 for spirituality vs control group; P=.034 for spirituality vs meditation group). Mean improvement in the SF-36 mental component summary score was 14.4 (48.6%) for the spirituality group, 7.1 (22.3%) for the meditation group, and 4.7 (16.1%) for the control group (P<.001 for spirituality vs control group; P=.029 for spirituality vs meditation group). At 12 weeks, POMS and SF-36 scores remained significantly different from baseline for the spirituality group.
RCT Entities:
CONTEXT: Although epidemiological studies have reported protective effects of religion and spirituality on mental health, it is unknown whether spirituality can be used as an intervention to improve psychological well-being. OBJECTIVE: To evaluate the efficacy of a home study-based spirituality program on mood disturbance in emotionally distressed patients. DESIGN, SETTING, AND PARTICIPANTS: A non-blinded, randomized, wait list-controlled trial of 165 individuals with mood disturbance [score of >40 on the Profile of Mood States (POMS)] were recruited from primary care clinics in a Canadian city between August 2000 and March 2001. INTERVENTIONS:Participants were randomized to a spirituality group (an 8-week audiotaped spirituality home-study program), a mindfulness meditation-based stress reduction group (attendance at facilitated classes for 8 weeks), or a wait-list control group (no intervention for 12 weeks). MAIN OUTCOME MEASURES: Primary outcomes were mood disturbance, measured using POMS, and quality of life, measured using the SF-36, a short-form health survey with 36 questions. The POMS and the SF-36 were completed at baseline, at 8 weeks, and at 12 weeks. RESULTS: At the end of the 8-week intervention period, the mean POMS score improvement was -43.1 (-45.7%) for the spirituality group, -22.6 (-26.3%) for the meditation group, and -10.3 (11.3%) for the control group (P<.001 for spirituality vs control group; P=.034 for spirituality vs meditation group). Mean improvement in the SF-36 mental component summary score was 14.4 (48.6%) for the spirituality group, 7.1 (22.3%) for the meditation group, and 4.7 (16.1%) for the control group (P<.001 for spirituality vs control group; P=.029 for spirituality vs meditation group). At 12 weeks, POMS and SF-36 scores remained significantly different from baseline for the spirituality group.
Authors: Madhav Goyal; Sonal Singh; Erica M S Sibinga; Neda F Gould; Anastasia Rowland-Seymour; Ritu Sharma; Zackary Berger; Dana Sleicher; David D Maron; Hasan M Shihab; Padmini D Ranasinghe; Shauna Linn; Shonali Saha; Eric B Bass; Jennifer A Haythornthwaite Journal: JAMA Intern Med Date: 2014-03 Impact factor: 21.873
Authors: Cynthia R Gross; Mary Jo Kreitzer; Maryanne Reilly-Spong; Nicole Y Winbush; E Katherine Schomaker; William Thomas Journal: Clin Trials Date: 2009-02 Impact factor: 2.486
Authors: Marcelo M P Demarzo; Jesús Montero-Marin; Pim Cuijpers; Edurne Zabaleta-del-Olmo; Kamal R Mahtani; Akke Vellinga; Caterina Vicens; Yolanda López-del-Hoyo; Javier García-Campayo Journal: Ann Fam Med Date: 2015-11 Impact factor: 5.166
Authors: Julieta Galante; Claire Friedrich; Anna F Dawson; Marta Modrego-Alarcón; Pia Gebbing; Irene Delgado-Suárez; Radhika Gupta; Lydia Dean; Tim Dalgleish; Ian R White; Peter B Jones Journal: PLoS Med Date: 2021-01-11 Impact factor: 11.069
Authors: Thomas J Morledge; Didier Allexandre; Emily Fox; Alex Z Fu; Mitchell K Higashi; Denise T Kruzikas; Sissi V Pham; Pat Ray Reese Journal: Ann Behav Med Date: 2013-10